RxDoctor Payments Data

Sheila Putman, DO

Otolaryngology/Facial Plastic Surgery · Myrtle Beach, SCNPI 1053675819

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 81 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 19.2% — the pattern of someone who eats at a lot of different presentations.

$2,520in general payments, 2019–2025

Across 81 payments — averaging $31.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$483
  • Medtronic$408
  • Optinose US, Inc.$287
  • Intersect ENT, Inc.$228
  • Access Pro Medical, LLC$228
  • Acclarent, Inc$186
  • plus $701 from 14 others

What the payments were for

  • Food & beverage$2,520100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few otolaryngology/facial plastic surgery providers in South Carolinato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$264,621
Medicare patients
636
Services billed
5,148

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab23$86,681
Ipratropium Bromide100$4,475
Fluticasone Propionate234$3,213
Epinephrine21$2,898
Azelastine Hcl47$1,288
Pantoprazole Sodium92$1,149
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav69$927
Mometasone Furoate12$541
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip49$522
Omeprazole44$451
Fluconazole37$396
Famotidine43$353
CefuroximeCefuroxime Axetil11$347
Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid25$315
Doxycycline Hyclate23$296

Paid to pharmacies, not to this prescriber.

Other otolaryngology/facial plastic surgery in Myrtle Beach

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →